Cristina V. Oliveira
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Physical illness in schizophrenia and the role of tolerability in antipsychotic selection: an expert consensus with a focus on cariprazine.
Journal: Annals of general psychiatry
Published: September 27, 2024
Blood Cell Count Ratios at Baseline are Associated with Initial Clinical Response to Clozapine in Treatment-Resistant, Clozapine-Naïve, Schizophrenia-Spectrum Disorder.
Journal: Pharmacopsychiatry
Published: April 15, 2024
Anthropometry in antipsychotic-naïve first-episode psychosis patients: An exploratory approach to the role of environmental early life events in two independent samples.
Journal: Schizophrenia research
Published: August 01, 2023
Nurse-led lifestyle intervention in a cohort of schizophrenia patients treated with clozapine.
Journal: Archives of psychiatric nursing
Published: June 16, 2022
Antipsychotic-Associated Weight Gain and Clinical Improvement Under Clozapine Treatment.
Journal: Journal of clinical psychopharmacology
Published: December 20, 2021
Antipsychotic-induced weight gain and birth weight in psychosis: A fetal programming model.
Journal: Journal of psychiatric research
Published: December 21, 2018
Food craving and consumption evolution in patients starting treatment with clozapine.
Journal: Psychopharmacology
Published: November 14, 2018
Blood cell count in antipsychotic-naive patients with non-affective psychosis.
Journal: Early intervention in psychiatry
Published: October 17, 2016
Metabolic syndrome or glucose challenge in first episode of psychosis?
Journal: European psychiatry : the journal of the Association of European Psychiatrists
Published: June 22, 2016
Abnormal glycemic homeostasis at the onset of serious mental illnesses: A common pathway.
Journal: Psychoneuroendocrinology
Published: February 16, 2016
Comparison of serum BDNF levels in deficit and nondeficit chronic schizophrenia and healthy controls.
Journal: Psychiatry research
Published: January 22, 2014
Double-blind, placebo-controlled study of the efficacy of reboxetine and citalopram as adjuncts to atypical antipsychotics for negative symptoms of schizophrenia.
Journal: The Journal of clinical psychiatry
Published: April 23, 2013
Last Updated: 09/26/2026